Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reoperation for adrenocortical neoplasms.

James A Lee1, Quan-Yang Duh

  • 1Department of Surgery, San Francisco Medical Center, University of California, 4150 Clement Street, 94121, USA. duhq@surgery.ucsf.edu

Current Treatment Options in Oncology
|August 19, 2006
PubMed
Summary

Adrenocortical cancer is a deadly disease. Surgical re-resection offers the best hope for controlling recurrence and metastasis, while new treatments are in development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

What Price Would You Pay to Avoid a Thyroidectomy Scar?

World journal of surgery·2026
Same author

More liberal use of bilateral adrenalectomy for bilateral adrenal tumours with cortisol excess.

The lancet. Diabetes & endocrinology·2026
Same author

Parathyroid autofluorescence: A conditionally cost-effective tool to reduce postoperative hypocalcemia after total thyroidectomy.

Surgery·2025
Same author

Short-term outcomes in radiofrequency ablation for the primary treatment of T1N0M0 papillary thyroid carcinomas.

American journal of surgery·2025
Same author

Unpacking the Benefits and Trade-offs of Scarless Thyroidectomy.

JAMA surgery·2025
Same author

Near-Infrared Autofluorescence for Parathyroid Detection During Endocrine Neck Surgery: A Randomized Clinical Trial.

JAMA surgery·2025

Area of Science:

  • Oncology
  • Surgical Oncology

Background:

  • Adrenocortical cancer is a rare and aggressive endocrine malignancy with high mortality.
  • Current treatments offer limited efficacy, highlighting the need for improved therapeutic strategies.

Purpose of the Study:

  • To review the current management of adrenocortical cancer, focusing on surgical resection and emerging therapies.
  • To emphasize the role of surgical re-resection in managing recurrent or metastatic disease.

Main Methods:

  • Review of existing literature on adrenocortical cancer treatment.
  • Analysis of the efficacy of surgical resection, re-resection, and debulking.
  • Discussion of novel therapeutic approaches currently in preclinical development.

Main Results:

  • Surgical resection is the only curative option for adrenocortical cancer.
  • Re-resection of local recurrence and metastases offers the best chance for disease control and survival.
  • Tumor debulking can manage symptoms in advanced cases.
  • Current chemotherapy and radiotherapy show limited effectiveness.

Conclusions:

  • Aggressive surgical management, including re-resection, is crucial for improving outcomes in adrenocortical cancer.
  • Emerging treatments like radiofrequency ablation and targeted therapies hold promise for future treatment paradigms.

Related Experiment Videos